Conceivable Breast December 11, 2023 This look at 4732 female BRCA carriers treated for breast cancer at age 40 or younger reveals 1 in 5…
You can keep CATNON Central Nervous System May 19, 2021 Top Line: First interim results of the CATNON trial demonstrated a big benefit with the…
RSVP Other August 24, 2023 To the RSV prevention party. The past three months alone have brought historic FDA approvals…
Etymology Technique December 27, 2022 December 27, 2022 Etymology. If anyone says they’re not at least a little confused…
Personal touch Lung September 25, 2023 Top Line: Can SABR dose be individualized for patients with lung tumors?The Study: In practice,…
In orbit Other April 20, 2023 Regional outpatient clinics located a few to several miles from large academic centers have become…
Potential Other November 6, 2023 This fascinating basic science work! reveals the GTP we all know and love is much…
Notable Gastrointestinal June 7, 2022 The outcomes of the Chinese phase 3 NOTABLE trial that demonstrated across 92 patients with…
Squam game Gastrointestinal April 25, 2023 Top Line: Could concurrent immunotherapy improve the response rate for unresectable esophageal SCC treated with…
No man’s land Other October 17, 2022 Almost any type of re-irradiation is (unfairly?) lumped in with a Hail Mary attempt with…
In circulation Gastrointestinal September 26, 2023 A large prospective analysis of 147 patients treated for esophageal squamous cell carcinoma in Hong…
Phased Lung May 2, 2023 Top Line: How safe and effective is hypofractionated chemoradiation for stage III NSCLC?The Study: For…
Everything in its place Lung November 27, 2023 Top Line:Immune checkpoint inhibition as consolidation for responders to definitive chemoradiation is the current standard…
Slow simmer Lung August 15, 2023 The SINDAS trial established the safety and efficacy of combining radiation and EGFR-targeted therapy (erlotinib…
